Predictors of hepatocellular carcinoma in chronic hepatitis B patients
Not Applicable
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0002113
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Patients diagnosed as chronic hepatitis B in Seoul National University Bundang Hospital, Seoul National University hospital or Borame munincipal hospital and received ultrasound and alpha-fetoprotein examination for two or more times between 2003-3-1 and 2017-2-28.
Exclusion Criteria
1. Diagnosis of hepatoma or other malignance before or 6 months after enrollment
2. Coinfection with hepatitis C virus or human immunodeficiency virus
3. Duration of follow-up < 12 months
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method develpment of hepatocellular carcinoma: diagnosed by dynamic contrast-enhanced imaging
- Secondary Outcome Measures
Name Time Method